New Triplet, New Standard of Care in Relapsed Myeloma? New Triplet, New Standard of Care in Relapsed Myeloma?

A new triplet regimen -- carfilzomib, dexamethasone, and daratumumab -- has shown good results in patients with relapsed or refractory multiple myeloma.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news